Effectiveness and Safety of Anlotinib Monotherapy for Patients with Extensive-stage Small-Cell Lung Cancer Who Progressed to Chemotherapy: A Real-world Exploratory Study

BACKGROUND: Anlotinib demonstrated promising efficacy for patients with extensive-stage small-cell lung cancer (ES-SCLC) in clinical trials. However, the real-world evidence of anlotinib monotherapy in ES-SCLC was still limited currently. Therefore, present study was to investigate the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yonghui, Sun, Zhenqing, Sun, Wei, Wang, Haibo, Zu, Jinchi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793436/
https://www.ncbi.nlm.nih.gov/pubmed/35095286
http://dx.doi.org/10.1177/11795549211067184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793436/
https://www.ncbi.nlm.nih.gov/pubmed/35095286
http://dx.doi.org/10.1177/11795549211067184

Ejemplares similares